148.10
price up icon3.80%   5.32
 
loading

Iqvia Holdings Inc Borsa (IQV) Ultime notizie

pulisher
Jun 03, 2025

IQVIA to raise $2B via senior notes offering to repay debt - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA announces pricing of senior notes - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA prices $2 billion senior notes offering By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offe - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offering - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Inc. (IQV) Secures $2 Billion in Senior Notes Offering - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Holdings Announces $2 Billion Senior Notes Offering - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing of Senior Notes | IQV Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Prices $2 Billion Senior Notes Due 2032 - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing Of Senior Notes - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA prices $2 billion senior notes offering - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing of Senior Notes - Business Wire

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Offering of Senior Notes - BioSpace

Jun 02, 2025
pulisher
Jun 02, 2025

Iqvia Plans $2 Billion Notes Offering - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Offering of Senior Notes | IQV Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA plans $2 billion senior notes offering by 2032 - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Iqvia Announces Offering Of Senior Notes - marketscreener.com

Jun 02, 2025
pulisher
May 27, 2025

IQVIA Holdings Inc (IQV) Trading 3.28% Higher on May 27 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus

May 27, 2025
pulisher
May 27, 2025

IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com

May 27, 2025
pulisher
May 25, 2025

IQVIA’s SWOT analysis: healthcare data giant faces industry headwinds - Investing.com Australia

May 25, 2025
pulisher
May 25, 2025

IQVIA’s SWOT analysis: healthcare data giant faces industry headwinds By Investing.com - Investing.com Nigeria

May 25, 2025
pulisher
May 23, 2025

IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock? - MSN

May 23, 2025
pulisher
May 23, 2025

IQVIA (IQV) Projects Global Cancer Drug Spending to Hit $441B by 2029 - GuruFocus

May 23, 2025
pulisher
May 23, 2025

(IQV) Trading Advice - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

IQV: Cautious Outlook Amidst Delayed Decisions | IQV Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

IQVIA Holdings Inc (IQV) Stock Price Down 3.4% on May 21 - GuruFocus

May 22, 2025
pulisher
May 21, 2025

IQVIA Stock: Is Wall Street Bullish or Bearish? - Barchart.com

May 21, 2025
pulisher
May 19, 2025

IQVIA (IQV) Stock Sees Analyst Target Price Adjustment by JP Mor - GuruFocus

May 19, 2025
pulisher
May 19, 2025

IQVIA (IQV) Stock Sees Analyst Target Price Adjustment by JP Morgan | IQV Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty - Yahoo Finance

May 19, 2025
pulisher
May 16, 2025

IQVIA Holdings (NYSE:IQV) Partners With SCRI Innovations To Enhance Global Oncology Trials - Yahoo

May 16, 2025
pulisher
May 16, 2025

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

IQVIA Teams Up With SCRI to Expedite Development of New Cancer Therapies - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

IQVIA And SCRI Collaborate To Accelerate Global Oncology Trials - marketscreener.com

May 16, 2025
pulisher
May 15, 2025

Is IQVIA Holdings Inc. (IQV) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

Deep Dive Into IQVIA Hldgs Stock: Analyst Perspectives (10 Ratings) - Benzinga

May 15, 2025
pulisher
May 15, 2025

IQVIA Holdings (IQV): Analyst Maintains Rating, Lowers Price Tar - GuruFocus

May 15, 2025
pulisher
May 15, 2025

IQVIA Holdings (IQV): Analyst Maintains Rating, Lowers Price Target | IQV Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Mizuho Adjusts Price Target for Iqvia (IQV) to $190 | IQV Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Mizuho Adjusts Price Target on IQVIA Holdings to $190 From $210, Maintains Outperform Rating - marketscreener.com

May 15, 2025
pulisher
May 14, 2025

IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 14, 2025
pulisher
May 14, 2025

Questex’s Fierce Biotech Announces 2025 Fierce CRO Award Finalists - GlobeNewswire Inc.

May 14, 2025
pulisher
May 14, 2025

Positive Outlook for IQVIA Holdings Driven by Resilient TAS, Strategic Capital Allocation, and R&D Strength - TipRanks

May 14, 2025
pulisher
May 13, 2025

IQVIA Holdings Inc. (NYSE:IQV) Q1 2025 Earnings Call Transcript - MSN

May 13, 2025
pulisher
May 13, 2025

IQVIA at BofA Securities 2025: Strong Q1 Amid Market Challenges By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

IQVIA at BofA Securities 2025: Strong Q1 Amid Market Challenges - Investing.com

May 13, 2025
pulisher
May 13, 2025

Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance

May 13, 2025
diagnostics_research MTD
$1,173.29
price up icon 1.41%
$160.15
price down icon 0.34%
diagnostics_research LH
$250.51
price up icon 1.07%
diagnostics_research WAT
$349.39
price up icon 1.66%
diagnostics_research DGX
$173.34
price down icon 0.09%
Capitalizzazione:     |  Volume (24 ore):